发明名称 LIPID FORMULATION
摘要 The invention features an improved lipid formulation comprising a cationic lipid of formula (A), a neutral lipid, a sterol and a PEG or PEG-modified lipid, where R1 and R2 are independently alkyl, alkenyl or alkynyl, each can be optionally substituted, and R3 and R4 are independently lower alkyl or R3 and R4 can be taken together to form an optionally substituted heterocyclic ring. In one embodiment, R1 and R2 are independently selected from oleoyl, pamitoyl, steroyl, linoleyl and R3 and R4 are methyl. Also disclosed are targeting lipids, and specific lipid formulations comprising such targeting lipids.
申请公布号 US2012101148(A1) 申请公布日期 2012.04.26
申请号 US201013147189 申请日期 2010.01.29
申请人 AKING AKIN;QUERBES WILLIAM;WONG FRANCES M.P.;DORKIN JOSEPH R.;QIN XIAOJUN;CANTLEY WILLIAM;BORODOVSKY ANNA;DE SOMA;MANOHARAN MUTHIAH;JAYARAMAN MUTHUSAMY;RAJEEV KALLANTHOTTATHIL G.;ALNYLAM PHARMACEUTICALS, INC. 发明人 AKING AKIN;QUERBES WILLIAM;WONG FRANCES M.P.;DORKIN JOSEPH R.;QIN XIAOJUN;CANTLEY WILLIAM;BORODOVSKY ANNA;DE SOMA;MANOHARAN MUTHIAH;JAYARAMAN MUTHUSAMY;RAJEEV KALLANTHOTTATHIL G.
分类号 A61K31/713;A61K31/7088;A61K31/7105;A61K47/28;A61K47/42;A61P43/00 主分类号 A61K31/713
代理机构 代理人
主权项
地址